The Fredric G. Levin Lung CARE Symposium

The Fredric G. Levin Lung CARE Symposium is organized by Brigham and Women's Hospital (BWH) / Harvard Medical School (HMS) and will be held from Mar 27 - 28, 2025 at Institute for Human & Machine Cognition (IHMC), Pensacola, Florida, United States of America.

Course Overview:
Join us for an exclusive medical gathering at the prestigious BWH/HMS Lung Cancer Symposium in beautiful Pensacola, Florida. This annual event unites medical professionals in a shared mission to advance knowledge and expertise in the ever-evolving field of Lung Care. This year, we're embracing the theme of "community" to connect, inspire, and broaden our horizons while staying firmly rooted in our core focus – Lung Care. Our dynamic agenda encompasses a diverse range of topics to empower you with cutting-edge insights. 

Discover how the dynamics of lung cancer treatment are evolving as our understanding of this unique disease deepens. Despite established guidelines, variability in patient management remains a challenge. Learn how to align with the National Comprehensive Cancer Network's (NCCN) guidelines, and stay updated on staging, treatment, and indications for neoadjuvant and adjuvant therapy. 

Uncover the pivotal role of immunotherapy in treating lung cancer patients. Our expert speakers will deliver engaging, topical lectures to broaden your knowledge, and open new avenues of treatment. 

Agenda Highlights: 

• Surgical Innovation: Unveiling the latest techniques and breakthroughs in lung cancer surgery. 
• Lung Cancer Diagnosis and Screening: Exploring innovative methods for early detection. 
• Resources for Lung Cancer Screening: Equipping you with the essential tools for effective screening. 
• Lung Cancer Screening Programs: A deep dive into program development and best practices.
• The Importance of Multidisciplinary Collaboration: Fostering teamwork for comprehensive patient care.
• Challenges in Coordinating Multidisciplinary Care: Navigating the complexities of collaboration.
• Clinical Pathways and Collaboration: Streamlining patient journeys for optimal outcomes.
• Palliative Care: Enhancing the quality of life for lung cancer patients.
• Medical Risk and Error: Strategies for minimizing risk and maximizing patient safety. 

Learning Objectives:
Upon completion of this activity, participants will be able to:

• Review the guidelines established by the Fleischner Society and American College of Chest Physicians regarding the evaluation and management of pulmonary nodules. 
• Identify the spectrum of radiologic appearance of pulmonary nodules and the range of differential diagnoses that may guide the choice of imaging. 
• Discuss the spectrum of radiologic appearance of pulmonary nodules and the range of differential diagnoses that may guide the choice of imaging. 
• Analyze the current role of strategies for lung cancer diagnosis and staging. 
• Evaluate the advantages and limitations of limited resection for early-stage lung cancer.
• Analyze the technical challenges and results of extended pulmonary resection. 
• Assess the current role of stereotactic body radiotherapy (SBRT) in the management of early stage non–small cell lung cancer.
• Demonstrate the use of state-of-the-art tools to diagnose and stage lung cancer. 
• Demonstrate the use of new treatment technologies 
• Review new research related to pulmonary nodules and lung cancer.